Renal graft rejection or urinary tract infection? The value of myeloperoxidase, C-reactive protein, and alpha 2-macroglobulin in the urine

被引:29
作者
Steinhoff, J
Einecke, G
Niederstadt, C
DeGroot, K
Fricke, L
Machnik, H
Sack, K
机构
[1] Department of Internal Medicine I, University of Lübeck
[2] Department of Internal Medicine I, University of Lübeck, D-23538 Lübeck
关键词
D O I
10.1097/00007890-199708150-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous investigations have shown that the determination of two acute-phase proteins in the urine, C-reactive protein (CRPu) and alpha 2-macroglobulin (alpha 2-MGu), allows a noninvasive diagnosis of acute renal graft dysfunction. A reliable differentiation between rejection and urinary tract infection can be made only when considering the C-reactive protein in serum and urine at the same time (CRPs:CRPu ratio). Therefore, a diagnostic procedure independent of parameters other than urinary proteins is needed, As granulocytes play only a minor role in graft rejection but are a common feature in urinary tract infection, we determined a marker of granulocytes (myeloperoxidase) in urine (MPOu). Eighty-nine renal transplant recipients were included in the study. In normal courses, CRPu, alpha u2-RMGu, and MPOu were within the normal range. In 15 cases of acute interstitial rejection, an increased excretion of CRPu and alpha 2-MGu could be confirmed, but MPO could not be detected. On the occasion of acute vascular rejection (n=6), with the exception of one case, MPOu could not be observed, The pattern of the three urinary proteins differed in urinary tract infections (n=40): MPOu could be detected in all cases, CRPu in 50% of cases, and alpha 2-MGu in 73% of cases. In patients with cytomegalovirus infection (n=7), no MPOu, CRPu, or alpha 2-MGu was found, In conclusion, the simultaneous measurement of the three proteins allows a complete, noninvasive, differential diagnostic procedure of renal graft dysfunction.
引用
收藏
页码:443 / 447
页数:5
相关论文
共 22 条
[1]  
ARIMURA Y, 1993, CLIN NEPHROL, V40, P256
[2]   THE DETECTION OF HUMAN CYTOMEGALOVIRUS IMMEDIATE EARLY ANTIGEN IN PERIPHERAL-BLOOD LEUKOCYTES [J].
BEIN, G ;
BITSCH, A ;
HOYER, J ;
KIRCHNER, H .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 137 (02) :175-180
[3]  
BRAUN J, 1986, CLIN CHEM, V32, P743
[4]   NEUTROPHIL ACTIVATION IN-VITRO AND IN-VIVO IN WEGENERS GRANULOMATOSIS [J].
BROUWER, E ;
HUITEMA, MG ;
MULDER, AHL ;
HEERINGA, P ;
VANGOOR, H ;
TERVAERT, JWC ;
WEENING, JJ ;
KALLENBERG, CGM .
KIDNEY INTERNATIONAL, 1994, 45 (04) :1120-1131
[5]  
COUSER WG, 1993, CLIN INVESTIGATOR, V71, P808
[6]   ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AND ANTIENDOTHELIAL CELL ANTIBODIES [J].
DILLON, MJ ;
TIZARD, EJ .
PEDIATRIC NEPHROLOGY, 1991, 5 (02) :256-259
[7]   HYALURONAN AND MYELOPEROXIDASE IN HUMAN PERITONEAL-FLUID DURING GENITAL INFLAMMATION [J].
EDELSTAM, GAB ;
LUNDKVIST, O ;
VENGE, P ;
LAURENT, TC .
INFLAMMATION, 1994, 18 (02) :141-149
[8]  
FRASER PA, 1995, GENITOURIN MED, V71, P176
[9]   Serum C-reactive protein - A useful and economical marker of immune activation in renal transplantation [J].
Harris, KR ;
Digard, NJ ;
Lee, HA .
TRANSPLANTATION, 1996, 61 (11) :1593-1600
[10]   ASSESSMENT OF MYELOPEROXIDASE ACTIVITY IN WHOLE RAT-KIDNEY [J].
HILLEGASS, LM ;
GRISWOLD, DE ;
BRICKSON, B ;
ALBRIGHTSONWINSLOW, C .
JOURNAL OF PHARMACOLOGICAL METHODS, 1990, 24 (04) :285-295